Cancer statistics, 2009

Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Thun, M. J.·2009·CA: A Cancer Journal for Clinicians

Cited by (1,040)

Items 301–400 of 1,040

  1. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer
    Brittney D. Jung-Hynes, Russel Joseph Reiter, Nihal Ahmad · 2009 · Journal of Pineal Research
  2. Inhibition of Focal Adhesion Kinase by PF-562,271 Inhibits the Growth and Metastasis of Pancreatic Cancer Concomitant with Altering the Tumor Microenvironment
    Jayme B. Stokes, Sara J. Adair, Jill K. Slack‐Davis, Dustin M. Walters, Robert W. Tilghman, E. Daniel Hershey, Bryce T. Lowrey, Keena S. Thomas, Amy H. Bouton, Rosa F. Hwang et al. · 2011 · Molecular Cancer Therapeutics
  3. Tumor-Derived Chemokine CCL5 Enhances TGF-β–Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
    Li-Yuan Chang, Yung‐Chang Lin, Jayashri Mahalingam, Ching‐Tai Huang, Ten-Wen Chen, Chiao-Wen Kang, Huimin Peng, Yu‐Yi Chu, Jy‐Ming Chiang, Avijit Dutta et al. · 2012 · Cancer Research
  4. Epidemiology of cancer of the small intestine
    Sai Yi Pan · 2011 · World Journal of Gastrointestinal Oncology
  5. Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer
    Markus Riester, Jennifer M. Taylor, Andrew H. Feifer, Theresa M. Koppie, Jonathan E. Rosenberg, Robert J. Downey, Bernard H. Bochner, Franziska Michor A · 2012 · Clinical Cancer Research
  6. The Performance of MelaFind
    Gary D. Monheit, Armand B. Cognetta, Laura Korb Ferris, Harold S. Rabinovitz, Kenneth G. Gross, Mary C. Martini, James M. Grichnik, Martín C. Mihm, Victor Gerardo Prieto, Paul B. Googe et al. · 2010 · Archives of Dermatology
  7. Epidemiology of Ductal Carcinoma In Situ
    Karla M. Kerlikowske · 2010 · JNCI Monographs
  8. <i>KRAS</i> Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer
    Tie, Jeanne, Lipton, Lara, Desai, Jayesh, Gibbs, Peter, Jorissen, Robert N., Christie, Michael, Drummond, Katharine J., Thomson, Benjamin N.J., Usatoff, Valery, Evans, Peter M. et al. · 2011 · Clinical Cancer Research
  9. Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors
    Frederick R. Ueland, Christopher Philip DeSimone, Leigh G. Seamon, Rachel W. Miller, Scott T. Goodrich, Iwona Podzielinski, Lori J. Sokoll, Alan Smith, John Rensselaer van Nagell, Zhen Zhang · 2011 · Obstetrics and Gynecology
  10. Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma
    Sachin B. Wani, Gary W. Falk, Matt Hall, Srinivas Gaddam, Amy Wang, Neil Gupta, Mandeep Singh, Vikas Singh, Keng–Yu Chuang, Vikram Boolchand et al. · 2010 · Clinical Gastroenterology and Hepatology
  11. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc
    Zhe Chen, Huazong Zeng, Yong Guo, Pei Liu, Hui Pan, Anmei Deng, JIAN LI HU · 2010 · Journal of Experimental & Clinical Cancer Research
  12. Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis
    Mary E. Ropka, Jessica Keim‐Malpass, John T. Philbrick · 2010 · Journal of Clinical Oncology
  13. Implication of RNA-Binding Protein La in Proliferation, Migration and Invasion of Lymph Node-Metastasized Hypopharyngeal SCC Cells
    Gunhild Sommer, Carlos Rossa, Angela C. Chi, Brad W. Neville, Tilman Heise · 2011 · PLoS ONE
  14. Expression of M2-Polarized Macrophages is Associated with Poor Prognosis for Advanced Epithelial Ovarian Cancer
    Chunyan Lan, Xin Huang, Suxia Lin, Huiqiang Huang, Qi-Chun Cai, Ting Wan, Jiabin Lu, Jihong Liu · 2013 · Technology in Cancer Research & Treatment
  15. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management
    Tait D. Shanafelt, Paolo Ghia, Mark C. Lanasa, Ola Landgren, Andy C. Rawstron · 2010 · Leukemia
  16. miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS
    Bin Xu, Xiaobing Niu, Xiangxiang Zhang, Jun Tao, Deyao Wu, Zidun Wang, Pengchao Li, Wei Zhang, Hongfei Wu, Ninghan Feng et al. · 2010 · Molecular and Cellular Biochemistry
  17. What are the hallmarks of cancer?
    Yuri A. Lazebnik · 2010 · Nature reviews. Cancer
  18. miR‐301a as an NF‐κB activator in pancreatic cancer cells
    Zhongxin Lu, Yan Li, Apana A. Takwi, Benhui Li, Jingwen Zhang, Daniel J. Conklin, Ken H. Young, Robert C.G. Martin, Yong Li · 2010 · The EMBO Journal
  19. EGFR and KRAS mutations in lung carcinoma
    Shahreen Billah, John Stewart, Gregg Staerkel, Su Chen, Yun Gong, Ming Guo · 2011 · Cancer Cytopathology
  20. Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-κB and Src Protein Kinase Signaling Pathways
    Mehdi Shakibaei, Ali Mobasheri, Cora Lueders, Franziska Busch, Paviz Shayan, Ajay Goel · 2013 · PLoS ONE
  21. Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum
    Melissa S. DeRycke, Stefan E. Pambuccian, C. Blake Gilks, Steve E. Kalloger, Abderrezak Ghidouche, Marc Lopez, Robin Bliss, Melissa Ann Geller, Peter A. Argenta, Katherine M. Harrington et al. · 2010 · American Journal of Clinical Pathology
  22. Biodegradable Porous Silicon Barcode Nanowires with Defined Geometry
    Ciro Chiappini, Xuewu Liu, Jean Raymond Fakhoury, Mauro Ferrari B · 2010 · Advanced Functional Materials
  23. Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial
    David Robert Spigel, P. Townley, David Michael Waterhouse, Liang Fang, Ibrahim Adiguzel, Jane E. Huang, David Alan Karlin, Leonardo Nercolini Faoro, Frank A. Scappaticci, Mark A. Socinski · 2011 · Journal of Clinical Oncology
  24. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing
    David Basketter · 2012 · ALTEX
  25. The National Cancer Database report on advanced-stage epithelial ovarian cancer: Impact of hospital surgical case volume on overall survival and surgical treatment paradigm
    Robert E. Bristow, Bryan E. Palis, S. Dennis, William A. Cliby · 2010 · Gynecologic Oncology
  26. Intracellular and Extracellular MicroRNAs in Breast Cancer
    Claire Corcoran, Anne M. Friel, Michael Joe Duffy, John Paul Crown, Lorraine O’Driscoll · 2010 · Clinical Chemistry
  27. Diosgenin, a Steroidal Saponin, Inhibits Migration and Invasion of Human Prostate Cancer PC-3 Cells by Reducing Matrix Metalloproteinases Expression
    Pin-Shern Chen, Yuan‐Wei Shih, Hsiang-Ching Huang, Hsing-Wen Cheng · 2011 · PLoS ONE
  28. CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
    Seema Singh, Sanjeev K. Srivastava, A Bhardwaj, Laurie B. Owen, Ajay P. Singh · 2010 · British Journal of Cancer
  29. Targeting the MAPK pathway in melanoma: Why some approaches succeed and other fail
    Gajanan S. Inamdar, SubbaRao V. Madhunapantula, Gavin P. Robertson · 2010 · Biochemical Pharmacology
  30. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200
    Miharu Kobayashi, Carlos Salomón, Jorge Tapia, Sebastian Enrique Illanes, Murray David Mitchell, Gregory Edward Rice · 2014 · Journal of Translational Medicine
  31. Bacterial alterations in salivary microbiota and their association in oral cancer
    Wei-Hsiang Lee, Hui‐Mei Chen, Shun‐Fa Yang, Chao Liang, Chih-Yu Peng, Feng-Mao Lin, Lo‐Lin Tsai, Buor-Chang Wu, Chung‐Han Hsin, Chun‐Yi Chuang et al. · 2017 · Scientific Reports
  32. Medicinal mushrooms in supportive cancer therapies: an approach to anti-cancer effects and putative mechanisms of action
    Dilani D. De Silva, Sylvie Rapior, Françoise Fons, Ali Hassan Bahkali, Kevin D. Hyde · 2012 · Fungal Diversity
  33. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening
    Christopher D. Jensen, Douglas A. Corley, Virginia P. Quinn, Chyke A. Doubeni, Ann Graham Zauber, Jeffrey K. Lee, Wei K. Zhao, Amy R. Marks, Joanne E. Schottinger, Nirupa R. Ghai et al. · 2016 · Annals of Internal Medicine
  34. Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival
    RT Hoffmann, Philipp Marius Paprottka, Agnes Schön, Fabian Bamberg, Alexander Robert Haug, Eva-Maria Dürr, Barbara Rauch, Christoph Trumm, Tobias Franz Jakobs, Thomas K Helmberger et al. · 2011 · CardioVascular and Interventional Radiology
  35. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer
    Leonie Haverkamp, Maarten F. J. Seesing, Jelle P. H. Ruurda, Judith Boone, Richard van Hillegersberg · 2016 · Diseases of the Esophagus
  36. Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer
    Shain, A. Hunter, Giacomini, Craig P., Matsukuma, Karen, Karikari, Collins A., Bashyam, Murali D., Hidalgo, Manuel, Maitra, Anirban, Pollack, Jonathan R. · 2012 · Proceedings of the National Academy of Sciences
  37. Early Diagnosis of Pancreatic Cancer: Challenges and New Developments
    Sukhwinder Kaur, Michael J. Baine, Maneesh Jain, Aaron R. Sasson, Surinder K. Batra · 2012 · Biomarkers in Medicine
  38. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals
    Øyvind Holme, Michael Bretthauer, Atle Fretheim, Jan Odgaard‐Jensen, Geir S. Hoff · 2013 · Cochrane Database of Systematic Reviews
  39. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth
    Murali Mohan Yallapu, Diane M. Maher, Vasudha Sundram, Maria C. Bell, Meena Jaggi, Subhash C. Chauhan · 2010 · Journal of Ovarian Research
  40. Biology of premature ageing in survivors of cancer
    Cupit-Link, Margaret C., Kirkland, James L., Ness, Kirsten K., Armstrong, Gregory T., Tchkonia, Tamar, LeBrasseur, Nathan K., Armenian, Saro H., Ruddy, Kathryn J., Hashmi, Shahrukh K. · 2017 · ESMO Open
  41. A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma
    Patrick B. Johnston, David James Inwards, Joseph P. Colgan, Betsy R LaPlant, Brian Kabat, Thomas Matthew Habermann, Ivana N. Micallef, Luis F. Porrata, Stephen Maxted Ansell, Craig B. Reeder et al. · 2010 · American Journal of Hematology
  42. The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells
    Ryan Charles Pink, Priya Samuel, Davide Massa, Daniel Paul Caley, Susan Ann Brooks, David R. F. Carter · 2015 · Gynecologic Oncology
  43. Triple‐negative breast cancer in Hispanic patients
    Fernando Ulises Lara-Medina, Víctor M. Pérez-Sánchez, David Saavedra-Pérez, Mónika Blake-Cerda, Claudia Arce, Daniel Motola‐Kuba, Cynthia Mayte Villarreal-Garza, Ana Maria Gonzalez-Angulo, Enrique Bargalló, José Luis Aguilar et al. · 2011 · Cancer
  44. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth
    van den Heuvel, A. Pieter J., Jing, Junping, Wooster, Richard F., Bachman, Kurtis E. · 2012 · Cancer Biology &amp; Therapy
  45. Development of Central Nervous System Metastases in Patients with Advanced Non–Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib
    Stéphanie Héon, Beow Yong Yeap, Gregory Joseph Britt, Daniel Botelho Costa, Michael S. Rabin, David Michael Jackman, Bruce Evan Johnson · 2010 · Clinical Cancer Research
  46. DNA Mismatch Repair Gene Polymorphisms Affect Survival in Pancreatic Cancer
    Xiaoqun Dong, Yanan Li, Kenneth R. Hess, James L. Abbruzzese, Donghui Li · 2011 · The Oncologist
  47. Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer Growth
    Jian Zhang, Yuele Lu, Kenneth J. Pienta · 2010 · JNCI Journal of the National Cancer Institute
  48. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010
    Chakshu Sharma · 2011 · World Journal of Gastroenterology
  49. Previous Lung Diseases and Lung Cancer Risk: A Pooled Analysis From the International Lung Cancer Consortium
    Darren R. Brenner, Paolo Boffetta, Eric J. Duell, Heike Bickeböller, Albert Rosenberger, Valerie McCormack, Joshua E. Muscat, Ping Yang, H.‐Erich Wichmann, Irene Brueske-Hohlfeld et al. · 2012 · American Journal of Epidemiology
  50. MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma
    Kerstin Boll, Kristin Reiche, Katharina Kasack, Nora Mörbt, Antje Karen Kretzschmar, Janina Melanie Tomm, Gerald W.C.T Verhaegh, Jack A. Schalken, Martin von Bergen�, Friedemann Horn et al. · 2012 · Oncogene
  51. Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
    Tsutomu Kawaguchi, Shuhei Komatsu, Daisuke Ichikawa, Ryo Morimura, Masahiro Tsujiura, Hirotaka Konishi, Haruo Takeshita, Hiroaki Nagata, Tomohiro Arita, Shoji Hirajima et al. · 2013 · British Journal of Cancer
  52. Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
    Latifi, Ardian, Luwor, Rodney B., Bilandzic, Maree, Nazaretian, Simon, Stenvers, Kaye, Pyman, Jan, Zhu, Hongjian, Thompson, Erik W., Quinn, Michael A., Findlay, Jock K. et al. · 2012 · PLoS ONE
  53. Pathological Sprouting of Adult Nociceptors in Chronic Prostate Cancer-Induced Bone Pain
    Juan Miguel Jiménez‐Andrade, Aaron P. Bloom, JamesI . Stake, William G. Mantyh, Reid N. Taylor, Katie T. Freeman, Joseph R. Ghilardi, Michael A. Kuskowski, Patrick W. Mantyh · 2010 · Journal of Neuroscience
  54. Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer
    Guang‐Hui Liu, Zong‐Guang Zhou, Rong Chen, Mon-Jin Wang, Bin Zhou, Yuan Li, Xiao‐Feng Sun · 2013 · Tumor Biology
  55. Phase II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: ECOG 5203
    Weijing Sun, Mark E. Powell, Peter James O'Dwyer, Paul J. Catalano, Rafat Ansari, Al B. Benson · 2010 · Journal of Clinical Oncology
  56. Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer
    Rachel M. Ostroff, William L. Bigbee, Wilbur A. Franklin, Larry Gold, Mike Mehan, York E. Miller, Harvey Ira Pass, William N. Rom, Jill M. Siegfried, Alex Stewart et al. · 2010 · Nature Precedings
  57. Half-Antibody Functionalized Lipid−Polymer Hybrid Nanoparticles for Targeted Drug Delivery to Carcinoembryonic Antigen Presenting Pancreatic Cancer Cells
    Che‐Ming Jack Hu, Sharmeela Kaushal, Hop S. Tran Cao, Santosh Aryal, Marta Sartor, Sadik C. Esener, Michael Bouvet, Liangfang Zhang · 2010 · Molecular Pharmaceutics
  58. Comparative and Targeted Proteomic Analyses of Urinary Microparticles from Bladder Cancer and Hernia Patients
    Chien‐Lun Chen, Yue-Fan Lai, Petrus Tang, Kun‐Yi Chien, Jau‐Song Yu, Cheng-Han Tsai, Hsiao‐Wei Chen, Chih‐Ching Wu, Ting Chung, Chia‐Wei Hsu et al. · 2012 · Journal of Proteome Research
  59. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer
    Youwei Zhang, Rui Wang, Haizhu Song, Guichun Huang, Jun Yi, Yun Zheng, Jinghua Wang, Longbang Chen · 2011 · Cancer Letters
  60. A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
    Christina S. F. Yau, Laura J. Esserman, Dan H. Moore, Fred Waldman, John J. Sninsky, Christopher C. Benz · 2010 · Breast Cancer Research
  61. Non‐THC cannabinoids inhibit prostate carcinoma growthin vitroandin vivo: pro‐apoptotic effects and underlying mechanisms
    Luciano De PETROCELLIS, Alessia Ligresti, Aniello Schiano Moriello, Mariagrazia Iappelli, Roberta Verde, Colin G. Stott, Luigia Cristino, Pierangelo Orlando, Vincenzo Di Marzo · 2012 · British Journal of Pharmacology
  62. Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer
    ERIC C. KAUFFMAN, Brian D. Robinson, Martin Downes, Leagh G. Powell, Ming Ming Lee, Douglas S. Scherr, Lorraine J. Gudas, Nigel Patrick Mongan · 2011 · Molecular Carcinogenesis
  63. The Oncofertility Consortium—addressing fertility in young people with cancer
    Teresa K. Woodruff · 2010 · Nature Reviews Clinical Oncology
  64. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
    Catharine M. Sturgeon, Michael Joe Duffy, Barry R Hofmann, R. Lamerz, Herbert A. Fritsche, Katja N. Gaarenstroom, Johannes M.G. Bonfrèr, Thorsten Ecke, Herbert Barton Grossman, Peter Clive Hayes et al. · 2010 · Clinical Chemistry
  65. Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer
    Panagiotis Papageorgis, Kuang‐Hung Cheng, Sait Ozturk, Yi Gong, Arthur W. Lambert, Hamid M. Abdolmaleky, Jin‐Rong Zhou, Sam Thiagalingam · 2011 · Cancer Research
  66. Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)
    Poulam M. Patel, Stefan Suciu, Laurent Mortier, Wim H.J. Kruit, Caroline Robert, Dirk Schadendorf, Uwe Trefzer, Cornelis J.A. Punt, Reinhard Dummer, Neville G. P. Davidson et al. · 2011 · European Journal of Cancer
  67. Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes
    Christof Winter, Glen Kristiansen, Stephan Kersting, Janine Roy, Daniela Ellen Aust, Thomas Knösel, Petra Rümmele, Beatrix Jahnke, Vera Hentrich, Felix Rückert et al. · 2012 · PLoS Computational Biology
  68. OR Forum—A POMDP Approach to Personalize Mammography Screening Decisions
    Turgay Ayer, Oğuzhan Alagöz, Natasha K. Stout · 2012 · Operations Research
  69. Human Bone Marrow–Derived MSCs Can Home to Orthotopic Breast Cancer Tumors and Promote Bone Metastasis
    Robert H. Goldstein, Michaela Ruth Reagan, Kristen Anderson, David Lee Kaplan, Michael Rosenblatt · 2010 · Cancer Research
  70. Head and neck cancer: causes, prevention and treatment
    Ana Lívia Silva Galbiatti, João Armando Padovani-Junior, José Victor Maníglia, Cléa Dometilde Soares Rodrigues, Érika Cristina Pavarino, Eny Maria Goloni‐Bertollo · 2013 · Brazilian Journal of Otorhinolaryngology
  71. Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species
    Sung-Ung Kang, JH Cho, Jae Won Chang, Yoo Seob Shin, K I Kim, Jaeku Park, S S Yang, Lee Js, E Moon, K Lee et al. · 2014 · Cell Death and Disease
  72. MicroRNA‐125b suppresses the development of bladder cancer by targeting E2F3
    Li Ting Huang, Junhua Luo, Qingqing Cai, Qiuhui Pan, Hong Zeng, Zhenghui Guo, Wen Dong, Jian Huang, Tianxin Lin · 2010 · International Journal of Cancer
  73. Understanding Racial Disparities in Cancer Treatment and Outcomes
    Arden M. Morris, Kim Felder Rhoads, Steven Charles Stain, John D. Birkmeyer · 2010 · Journal of the American College of Surgeons
  74. EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
    Alfred S.L. Cheng, Suki S. Lau, Yangchao Chen, Yutaka Kondo, May S.M. Li, Hai Feng, Arthur K.-K. Ching, Kin Fai Cheung, Hoi Kin Wong, JOANNA H.M. TONG et al. · 2011 · Cancer Research
  75. Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non–Small-Cell Lung Cancer (NSCLC)
    S. Cedrés, Isaac Núñez, Marina Longo, Pablo Martínez, Eva Checa, Davis Yuri Torrejon, Enriqueta Felip · 2011 · Clinical Lung Cancer
  76. Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
    Andrew J. Armstrong, Elizabeth S. Garrett-Mayer, Ronald de Wit, Ian F. Tannock, Mario A. Eisenberger · 2009 · Clinical Cancer Research
  77. Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer
    Joseph A. Sparano, Molin Wang, Fengmin Zhao, Vered Stearns, Silvana Martino, Jennifer A. Ligibel, Edith A. Perez, Tom Saphner, Antonio C. Wolff, George W. Sledge et al. · 2012 · Cancer
  78. Identification of salivary metabolomic biomarkers for oral cancer screening
    Shigeo Ishikawa, Masahiro Sugimoto, Kenichiro Kitabatake, Ayako Sugano, Marina Nakamura, Miku Kaneko, Sana Ota, Kana Hiwatari, Ayame Enomoto, Tomoyoshi Soga et al. · 2016 · Scientific Reports
  79. Role of ferritin alterations in human breast cancer cells
    Svitlana Shpyleva, Volodymyr Tryndyak, Olga Kovalchuk, Athena Starlard‐Davenport, Vasyl Fedorovich Chekhun, Frederick A. Beland, Igor P. Pogribny · 2010 · Breast Cancer Research and Treatment
  80. Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer Decreases Distant Recurrence and Could Eradicate Local Recurrence
    Luiz Felipe de Campos‐Lobato, Luca Stocchi, André da Luz Moreira, Daniel P. Geisler, David W. Dietz, Ian C. Lavery, Victor W. Fazio, Matthew F. Kalady · 2011 · Annals of Surgical Oncology
  81. VISTA expressed in tumour cells regulates T cell function
    Kumuluzi Mulati, Junzo Hamanishi, Noriomi Matsumura, Kenji Chamoto, Nathan Mise, Kaoru Abiko, Tsukasa Baba, Ken D Yamaguchi, Naoki Horikawa, Ryusuke Murakami et al. · 2018 · British Journal of Cancer
  82. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells
    Lu Jiang, Xiqiang Liu, Zujian Chen, Yi Jin, Caroline E. Heidbreder, Antonia Kolokythas, Anxun Wang, Yang David Dai, Xiaofeng C. Zhou · 2010 · Biochemical Journal
  83. The grape antioxidant resveratrol for skin disorders: Promise, prospects, and challenges
    Mary Ann Ndiaye, Carol Philippe, Hasan Mukhtar, Nihal Ahmad · 2011 · Archives of Biochemistry and Biophysics
  84. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma
    Anupam Bishayee, Themos Politis, Altaf S. Darvesh · 2009 · Cancer Treatment Reviews
  85. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma
    Michelle A.T. Hildebrandt, Jian Hong Gu, Jun Lin, Yuguo Ye, W Tan, Pheroze Tamboli, Christopher G. Wood, Xifeng Wu · 2010 · Oncogene
  86. CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
    Holbrook E K Kohrt, Roch Houot, Matthew Jordan Goldstein, Kipp Weiskopf, Ash A. Alizadeh, Josh Brody, Antonia M. S. Müller, Russell Kent Pachynski, Debra Katherine Czerwinski, Steven E. Coutre et al. · 2010 · Blood · Retracted
  87. MicroRNAs and prostate cancer
    Yingxin Pang, Charles Y.F. Young, Huiqing Yuan · 2010 · Acta Biochimica et Biophysica Sinica
  88. Exercise-oncology research: Past, present, and future
    Lee W. Jones, Catherine M. Alfano · 2012 · Acta Oncologica
  89. Pterostilbene Is More Potent than Resveratrol in Preventing Azoxymethane (AOM)-Induced Colon Tumorigenesis via Activation of the NF-E2-Related Factor 2 (Nrf2)-Mediated Antioxidant Signaling Pathway
    Yi-Siou Chiou, Mei-Ling Tsai, Kalyanam Nagabhushanam, Yin-Jen Wang, Chih‐Hsiung Wu, Chi‐Tang Ho, Min‐Hsiung Pan · 2011 · Journal of Agricultural and Food Chemistry
  90. Down‐regulation of Notch‐1 and Jagged‐1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF‐κB signaling pathways
    Zhiwei Peter Wang, Yiwei Li, Sanjeev Banerjee, Dejuan Kong, Aamir Ahmad, Véronique Nogueira, Nissim Hay, Fazlul H. Sarkar · 2010 · Journal of Cellular Biochemistry · Retracted
  91. The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
    Susanna Leskelä, Luis Javier Leandro-Garcia, Marta Mendiola, Jorge Barriuso, Lucía Inglada‐Pérez, Inés G. Muñoz, Beatriz Martínez–Delgado, Andrés Redondo, J. de Santiago, Mercedes Robledo et al. · 2010 · Endocrine Related Cancer
  92. A high protein moderate carbohydrate diet fed at discrete meals reduces early progression of N-methyl-N-nitrosourea-induced breast tumorigenesis in rats
    Christopher J. Moulton, Rudy J. Valentine, Donald K. Layman, Suzanne Devkota, Keith W. Singletary, Matthew A. Wallig, Sharon Marie Donovan · 2010 · Nutrition & Metabolism
  93. Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer
    Philipp Harter, Mustafa Zelal Muallem, Christine Buhrmann, Dietmar Lorenz, Christine Kaub, Rita Hils, Stefan Kommoss, Florian Heitz, Alexander Traut, Andreas du Bois · 2011 · Gynecologic Oncology
  94. Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression
    Yingming Li, Majid Alsagabi, Danhua Fan, G. Steven Bova, Ahmed H. Tewfik, Scott M. Dehm · 2011 · Cancer Research
  95. Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms
    Yue, Wei, Wang, Ji‐Ping, Li, Yuebai, Fan, Ping, Liu, Guijian, Zhang, Nan, Conaway, Mark, Wang, Hongkun, Korach, Kenneth S., Bocchinfuso, Wayne et al. · 2010 · International Journal of Cancer
  96. The economic burden of prostate cancer
    Claus G. Roehrborn, Libby K. Black · 2011 · British Journal of Urology
  97. Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
    Robert John Amato, Robert E. Hawkins, Howard L. Kaufman, John A. Thompson, Piotr Tomczak, Cezary A. Szczylik, Mike McDonald, Sarah Eastty, William H. Shingler, Jackie de Belin et al. · 2010 · Clinical Cancer Research
  98. Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor
    Stephen J. Murphy, Steven N. Hart, Joema Felipe Lima, Benjamin R. Kipp, Mitchell L. Klebig, Jennifer L. Winters, Csilla Szabo, Lizhi Zhang, Bruce W. Eckloff, Gloria M. Petersen et al. · 2013 · Gastroenterology
  99. Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study
    Anke M. Leufkens, Daniel C. DeMarco, Amit Nath Rastogi, Paul Akerman, Kassem Azzouzi, Richard Ira Rothstein, Frank P. Vleggaar, Alessandro Repici, Giacomo Rando, Patrick I. Okolo III et al. · 2010 · Gastrointestinal Endoscopy
  100. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas
    S. Dennis, Oliver Zivanovic, Kimberly L. Levinson, Valentin Kolev, Jae Huh, Joseph A. Dottino, Ginger J. Gardner, Mario M. Leitão, Douglas A. Levine, Yukio Sonoda et al. · 2010 · Gynecologic Oncology